News
Weightwatchers and bariatric surgery had limited effects on the obese brain, but GLP-1s like Ozempic may mean new hope in ...
Estrogen generated in the brain may play a role in regulating appetite, potentially opening new avenues for treating obesity.
While the US leads in early-phase obesity trials and investment, the country also faces challenges in disease burden, trial ...
However, many on Wall Street believe that better days lie ahead for Novo Nordisk. Analysts expect this obesity drug stock to ...
Novo Nordisk CEO's ouster signals stiff competition in the obesity market, getting dominated by Eli Lilly, with Roche, ...
A survey of adults living with obesity and their physicians across seven countries reveals a high disconnect between their ...
Queen Latifah opens up about obesity and heart health risks for public awareness campaign, Truth About Weight.
CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...
A digital obesity clinic, Embla, is associated with 16.7% weight loss over 64 weeks, matching previous semaglutide trial ...
I worry about how these changes, which are occurring at the age of 13 or 14, might affect them later in life,” the study’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback